Dow Rises 100 Points; Silver Jumps 7%
U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining over 100 points on Friday.
Looking Into Syneos Health’s Recent Short Interest
Syneos Health's (NASDAQ:SYNH) short percent of float has risen 25.38% since its last report. The company recently reported that it has 1.67 million shares sold short, which is 1.63% of all regular shares that are available for trading.
Stocks That Hit 52-Week Lows On Friday
Friday's session saw 236 companies set new 52-week lows.
Nasdaq Turns Lower; Crude Oil Rises Sharply
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite turning lower on Friday.
Earnings Outlook For Syneos Health
Syneos Health (NASDAQ:SYNH) is set to give its latest quarterly earnings report on Friday, 2022-11-04. Here's what investors need to know before the announcement.
Analysts estimate that Syneos Health will report an earnings per share (EPS) of $1.32.
Phil, Inc. Forges Strategic Partnership With Syneos Health To Improve Patient Access To Prescriptions
Phil Inc., a patient access platform company that revolutionizes life science product commercialization with technology to improve patient prescription access, today announced an exclusive partnership with Syneos
JP Morgan Downgrades Syneos Health to Neutral, Lowers Price Target to $53
JP Morgan analyst Tycho Peterson downgrades Syneos Health (NASDAQ:SYNH) from Overweight to Neutral and lowers the price target from $85 to $53.
